Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig

The mammalian skin has long been considered to be poor in drug metabolism. However, many reports clearly show that most drug metabolizing enzymes also occur in the mammalian skin albeit at relatively low specific activities. This review summarizes the current state of knowledge on drug metabolizing enzymes in the skin of human, rat, and pig, the latter, because it is often taken as a model for human skin on grounds of anatomical similarities. However only little is known about drug metabolizing enzymes in pig skin. Interestingly, some cytochromes P450 (CYP) have been observed in the rat skin which are not expressed in the rat liver, such as CYP 2B12 and CYP2D4. As far as investigated most drug metabolizing enzymes occur in the suprabasal (i.e. differentiating) layers of the epidermis, but the rat CYP1A1 rather in the basal layer and human UDP-glucuronosyltransferase rather in the stratum corneum. The pattern of drug metabolizing enzymes and their localization will impact not only the beneficial as well as detrimental properties of drugs for the skin but also dictate whether a drug reaches the blood flow unchanged or as activated or inactivated metabolite(s).

[1]  Jagdish Singh,et al.  Effect of buffer pH, buffer concentration and skin with or without enzyme inhibitors on the stability of [Arg(8)]-vasopressin. , 2000, International journal of pharmaceutics.

[2]  T. Hardingham,et al.  The tissue content and turnover rates of intermediates in the biosynthesis of glycosaminoglycans in young rat skin. , 1968, The Biochemical journal.

[3]  Elaine Fuchs,et al.  Stem cells of the skin epithelium , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Rawlins,et al.  Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis , 1980, The British journal of dermatology.

[5]  J Kao,et al.  Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. , 1985, Toxicology and applied pharmacology.

[6]  J. Zatz,et al.  Effect of formulation on the delivery and metabolism of alpha-tocopheryl acetate. , 2001, Journal of cosmetic science.

[7]  A. Kalofoutis,et al.  Influence of oral isotretinoin on hepatic and cutaneous P-450-dependent isozyme activities , 1994, Archives of Dermatological Research.

[8]  A. Pfeifer,et al.  Cytochrome P450 expression and related metabolism in human buccal mucosa. , 2001, Carcinogenesis.

[9]  F. Oesch,et al.  Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver. , 1992, The Biochemical journal.

[10]  J. Höög,et al.  Expression and localization of human alcohol and aldehyde dehydrogenase enzymes in skin. , 1999, Biochemical and biophysical research communications.

[11]  B. Lacarelle,et al.  Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure. , 2002, Toxicology and applied pharmacology.

[12]  R. Kato,et al.  Purification and characterization of four catalytically active testosterone 6 beta-hydroxylase P-450s from rat liver microsomes: comparison of a novel form with three structurally and functionally related forms. , 1990, Journal of biochemistry.

[13]  F. Guengerich,et al.  Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. , 1993, Journal of medicinal chemistry.

[14]  S. Kitamura,et al.  Xanthine oxidase-catalyzed metabolism of 2-nitrofluorene, a carcinogenic air pollutant, in rat skin. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[15]  H. Korting,et al.  Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts , 1997, Pharmaceutical Research.

[16]  A. Cherniack,et al.  Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon. , 1984, Cancer research.

[17]  J. Maclouf,et al.  Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. , 1996, Experimental cell research.

[18]  S. Penco,et al.  Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  E. Jabs,et al.  Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. , 1994, The Journal of biological chemistry.

[20]  F. Guengerich,et al.  Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. , 1995, Chemical research in toxicology.

[21]  Jeffrey B. Cheng,et al.  De-orphanization of Cytochrome P450 2R1 , 2003, Journal of Biological Chemistry.

[22]  H. Mukhtar,et al.  Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. , 1984, The Journal of investigative dermatology.

[23]  G. Ferron,et al.  Quantitation of cytochrome P450 mRNA levels in human skin. , 2003, Analytical biochemistry.

[24]  F. Oesch,et al.  Mechanisms of Toxification and Detoxification which Challenge Drug Candidates and Drugs , 2007 .

[25]  H. Mukhtar,et al.  Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. , 1983, Biochemical and biophysical research communications.

[26]  S. Georgiou,et al.  Effects of Human Recombinant Interferon-α2b on P450-Dependent Isozymes in Rat Liver and Skin , 1995 .

[27]  J. Masferrer,et al.  COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. , 1998, Carcinogenesis.

[28]  J. Saurat,et al.  Topical β‐carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo , 2004, Experimental dermatology.

[29]  Jane Huggins Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. , 2003 .

[30]  A. Stinchcomb Xenobiotic Bioconversion in Human Epidermis Models , 2003, Pharmaceutical Research.

[31]  Gillian Smith,et al.  Localization of Cytochrome P450 CYP2S1 Expression in Human Tissues by In Situ Hybridization and Immunohistochemistry , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  B. Buzadžić,et al.  Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast. , 2001, Journal of dermatological science.

[33]  A. Weston,et al.  Metabolism and activation of benzo[a]pyrene by mouse and rat skin in short-term organ culture and in vivo. , 1982, Chemico-biological interactions.

[34]  H. Blom,et al.  Altered status of glutathione and its metabolites in cystinotic cells. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  G. Clawson,et al.  Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). , 2003, The Journal of investigative dermatology.

[36]  C. Gomez-Sanchez,et al.  Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. , 2002, The Journal of investigative dermatology.

[37]  R. Agarwal,et al.  Cytochrome P-450 and drug development for skin diseases. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[38]  D. Galter,et al.  Tissue- and species-specific expression patterns of class I, III, and IV Adh and Aldh1 mRNAs in rodent embryos , 2005, Cell and Tissue Research.

[39]  L. Perry,et al.  Delayed repair: the role of glutathione in a rat incisional wound model. , 1996, The Journal of surgical research.

[40]  P. Parvaz,et al.  Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death. , 2001, Toxicology.

[41]  A. Sakr,et al.  Characterization of Esterase and Alcohol Dehydrogenase Activity in Skin. Metabolism of Retinyl Palmitate to Retinol (Vitamin A) During Percutaneous Absorption , 1994, Pharmaceutical Research.

[42]  F. Oesch,et al.  Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. , 1980, Biochemical pharmacology.

[43]  H. Merk,et al.  Multiple Cytochrome P450–Isoenzymes mRNA Are Expressed in Dendritic Cells , 1999, International Archives of Allergy and Immunology.

[44]  D. Jerina,et al.  Role of cytochrome P450 enzyme induction in the metabolic activation of benzo[c]phenanthrene in human cell lines and mouse epidermis. , 1997, Chemical research in toxicology.

[45]  Y. Y. Wang,et al.  Disubstituted amino-, nitroso-, and nitrofluorenes: a physicochemical basis for structure-activity relationships in Salmonella typhimurium. , 1987, Environmental mutagenesis.

[46]  G. Siest,et al.  Reconstituted epidermis: a novel model for the study of drug metabolism in human epidermis. , 1990, The Journal of investigative dermatology.

[47]  B. Conway,et al.  Skin delivery potency and antitumor activities of temozolomide ester prodrugs. , 2006, Cancer letters.

[48]  A. R. Thitoff,et al.  Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology , 2004, International journal of toxicology.

[49]  H. Mukhtar,et al.  Glutathione S-transferases in human and rodent skin: multiple forms and species-specific expression. , 1991, The Journal of investigative dermatology.

[50]  R. J. Anderson,et al.  Sulfation of minoxidil by multiple human cytosolic sulfotransferases. , 1998, Chemico-biological interactions.

[51]  M. Rawlins,et al.  Drug Metabolism in Skin , 1980 .

[52]  L. Kopelovich,et al.  Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.

[53]  T. Abe,et al.  Characterization of Vitamin D-mediated induction of the CYP 24 transcription , 2004, Molecular and Cellular Endocrinology.

[54]  H. Merk,et al.  Die Wirkung kleinmolekularer Substanzen auf die menschliche Haut , 2004, Der Hautarzt.

[55]  P. Swaan,et al.  Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin. , 2002, Journal of pharmaceutical sciences.

[56]  M. Negishi,et al.  The structure, function, and regulation of cytochrome P450 2A enzymes. , 1997, Drug metabolism reviews.

[57]  H. Mukhtar,et al.  Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione S-transferase in liver and skin of the neonatal rat. , 1981, Drug metabolism and disposition: the biological fate of chemicals.

[58]  M. Meurer,et al.  Conversion of vitamin D3 to 1α,25‐dihydroxyvitamin D3 in human skin equivalents , 2000 .

[59]  K. Wittern,et al.  Comparison of Activities Dependent on Glutathione S-Transferase and Cytochrome P-450 IA1 in Cultured Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.

[60]  H. Merk,et al.  A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. , 2007, The Journal of investigative dermatology.

[61]  P. Zaphiropoulos,et al.  The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. , 2000, Genomics.

[62]  N. Fusenig,et al.  Induction of UDP-glucuronyltransferase and arylhydrocarbon hydroxylase activity in mouse skin and in normal and transformed skin cells in culture. , 1986, Biochemical pharmacology.

[63]  H. Mukhtar,et al.  Effect of topical application of clotrimazole to rats on epidermal and hepatic monooxygenase activities and cytochrome P-450 , 2004, Archives of Dermatological Research.

[64]  R. Bronaugh,et al.  Percutaneous Absorption and Metabolism of Coumarin in Human and Rat Skin , 1997, Journal of applied toxicology : JAT.

[65]  J. Heylings,et al.  Percutaneous absorption and metabolism of dinitrochlorobenzene in vitro , 2000, Archives of Toxicology.

[66]  D. Bikle,et al.  Vitamin D, calcium, and epidermal differentiation. , 1993, Endocrine reviews.

[67]  A. Conney,et al.  Inducibility of benzo [α] pyrene hydroxylase in human skin by polycyclic hydrocarbons , 1973, Clinical pharmacology and therapeutics.

[68]  M. Waterman,et al.  A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid* , 1998, The Journal of Biological Chemistry.

[69]  M. Taimi,et al.  A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid* , 2004, Journal of Biological Chemistry.

[70]  D. Hinshaw,et al.  Oxidant stress: the role of the glutathione redox cycle in skin preconditioning. , 1995, The Journal of surgical research.

[71]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[72]  D. Howes,et al.  TOXICOKINETICS AND METABOLISM , 2005 .

[73]  Liping Du,et al.  Differentiation-Specific Factors Modulate Epidermal CYP1–4 Gene Expression in Human Skin in Response to Retinoic Acid and Classic Aryl Hydrocarbon Receptor Ligands , 2006, Journal of Pharmacology and Experimental Therapeutics.

[74]  W. Baschong,et al.  Direct evidence for bioconversion of vitamin E acetate into vitamin E: an ex vivo study in viable human skin. , 2001, Journal of cosmetic science.

[75]  Camilla K. Smith,et al.  Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. , 2000, Toxicology and applied pharmacology.

[76]  F. Oesch,et al.  Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase. A general assay and kinetic properties. , 1976, European journal of biochemistry.

[77]  H. Mukhtar,et al.  Purification and characterization of NADPH‐cytochrome P‐450 reductase from rat epidermis , 1993, Journal of cellular biochemistry.

[78]  A. Guillouzo,et al.  In Vitro expression of drug metabolizing enzyme activities in human adult keratinocytes under various culture conditions and their response to inducers. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[79]  H. Mukhtar,et al.  Skin as a Portal of Entry for Systemic Effect: Xenobiotic Metabolism , 1990 .

[80]  H. Mukhtar,et al.  Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. , 1987, The Journal of investigative dermatology.

[81]  H. Merk,et al.  N-Acetylation of paraphenylenediamine in human skin and keratinocytes. , 2000, The Journal of pharmacology and experimental therapeutics.

[82]  R. Agarwal,et al.  Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[83]  R. Serda,et al.  Expression, structure‐function, and molecular modeling of vitamin D P450s , 2003, Journal of cellular biochemistry.

[84]  F. Watt,et al.  Cell shape controls terminal differentiation of human epidermal keratinocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[85]  G. Aldini,et al.  Detoxification of 4-hydroxynonenal (HNE) in keratinocytes: characterization of conjugated metabolites by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[86]  Dooley Tp Molecular biology of the human cytosolic sulfotransferase gene superfamily implicated in the bioactivation of minoxidil and cholesterol in skin. , 1999 .

[87]  F. Oesch,et al.  Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues. , 1990, Environmental health perspectives.

[88]  Gillian Smith,et al.  Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases , 2003, The Lancet.

[89]  S. Hoffman,et al.  Epidermal CYP2 family cytochromes P450. , 2004, Toxicology and applied pharmacology.

[90]  R. Bronaugh,et al.  Influence of metabolism in skin on dosimetry after topical exposure. , 1994, Environmental health perspectives.

[91]  S. Hotchkiss,et al.  Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes. , 2003, Toxicology.

[92]  A. Hiratsuka,et al.  Marked expression of glutathione S-transferase A4-4 detoxifying 4-hydroxy-2(E)-nonenal in the skin of rats irradiated by ultraviolet B-band light (UVB). , 1999, Biochemical and biophysical research communications.

[93]  A. Yarat,et al.  The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes. , 2001, Free radical biology & medicine.

[94]  R. Edwards,et al.  Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. , 2002, Biochemical and biophysical research communications.

[95]  A. Haberland,et al.  The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[96]  A. Kulkarni,et al.  Peroxidase, an alternate pathway to cytochrome P-450 for xenobiotic metabolism in skin: partial purification and properties of the enzyme from neonatal rat skin. , 1986, Journal of biochemical toxicology.

[97]  P. Woster,et al.  A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. , 2000, The Journal of investigative dermatology.

[98]  S. Hotchkiss,et al.  Comparativein VitroSkin Absorption and Metabolism of Coumarin (1,2-Benzopyrone) in Human, Rat, and Mouse , 1997 .

[99]  B. Bonnekoh,et al.  Induction and inhibition of NAD(P)H: quinone reductase in murine and human skin. , 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[100]  R. Bronaugh,et al.  Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[101]  A. Haberland,et al.  Cutaneous Estradiol Permeation, Penetration and Metabolism in Pig and Man , 2004, Skin Pharmacology and Physiology.

[102]  F. Oesch,et al.  Antibodies against homogeneous epoxide hydratase provide evidence for a single enzyme hydrating styrene oxide and benz(a)pyrene 4,5-oxide , 1976, Nature.

[103]  B. De Wever,et al.  Expression of type 1 5α‐reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin‐targeted androgen modulators , 2000, International journal of cosmetic science.

[104]  H. Mukhtar,et al.  Epidermal enzyme-mediated mutagenicity of the skin carcinogen, 2-aminoanthracene. , 1985, Mutation research.

[105]  D. Howes,et al.  Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[106]  K. Sugibayashi,et al.  Simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin after its topical application: the effect of enzyme distribution in skin. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[107]  C. Esser,et al.  Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. , 2003, The Journal of investigative dermatology.

[108]  C. Chesné,et al.  Culture and drug biotransformation capacity of adult human keratinocytes from post‐mortem skin , 1996, The British journal of dermatology.

[109]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[110]  B. Shroot,et al.  Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes , 1995, The British journal of dermatology.

[111]  H. Mukhtar,et al.  Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat. , 1989, The Journal of pharmacology and experimental therapeutics.

[112]  H. Maibach,et al.  Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. , 1993, Journal of pharmaceutical sciences.

[113]  K. Wong,et al.  Sulphate conjugation of minoxidil in rat skin. , 1993, Biochemical pharmacology.

[114]  P. Janssen,et al.  Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[115]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[116]  T. Kumaravel,et al.  In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl or N,N'-diacetyl metabolites. , 2006, Mutation research.

[117]  R. Bronaugh,et al.  Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. , 1989, Toxicology and applied pharmacology.

[118]  David E. Williams,et al.  Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases , 2006, Journal of Pharmacology and Experimental Therapeutics.

[119]  S. Georgiou,et al.  Effects of human recombinant interferon-alpha 2b on P450-dependent isozymes in rat liver and skin. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[120]  M. Taimi,et al.  CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids* , 2004, Journal of Biological Chemistry.

[121]  J. Whitlock The regulation of cytochrome P-450 gene expression. , 1986, Annual review of pharmacology and toxicology.

[122]  G. Winston,et al.  Oxidation of thiodiglycol (2,2′‐thiobis‐ethanol) by alcohol dehydrogenase: Comparison of human isoenzymes , 2000, Journal of biochemical and molecular toxicology.

[123]  J. Hansson,et al.  Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. , 1991, Cancer research.

[124]  P. Crooks,et al.  Physicochemical Evaluation, in Vitro Human Skin Diffusion, and Concurrent Biotransformation of 3-O-Alkyl Carbonate Prodrugs of Naltrexone , 2004, Pharmaceutical Research.

[125]  T. Kissel,et al.  The Human Keratinocyte Cell Line HaCaT: An In Vitro Cell Culture Model for Keratinocyte Testosterone Metabolism , 1999, Pharmaceutical Research.

[126]  H. Swanson,et al.  Alteration of keratinocyte differentiation and senescence by the tumor promoter dioxin. , 2003, Toxicology and applied pharmacology.

[127]  H. Swanson Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. , 2004, Chemico-biological interactions.

[128]  S. Slivka Testosterone metabolism in an in vitro skin model , 1992, Cell Biology and Toxicology.

[129]  S. Hotchkiss,et al.  Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. , 2003, Journal of dermatological science.

[130]  Peter G. Zaphiropoulos,et al.  RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver , 1999, Nucleic Acids Res..

[131]  P. G. Wells,et al.  Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. , 1996, Cancer research.

[132]  J. Marcos,et al.  A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. , 2004, European journal of biochemistry.

[133]  J. Bridges,et al.  UDP-glucuronosyltransferase activity in rat-and hairless mouse skin-microsomes. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[134]  W. Sippl,et al.  Skin Penetration and Metabolism of Topical Glucocorticoids in Reconstructed Epidermis and in Excised Human Skin , 1999, Pharmaceutical Research.

[135]  R. Teshima,et al.  mRNA Expression of Multiple Cytochrome P450 Isozymes in Four Types of Cultured Skin Cells , 2002, International Archives of Allergy and Immunology.

[136]  N. Ledirac,et al.  Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. , 1997, Toxicology and applied pharmacology.

[137]  P. Blain,et al.  Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. , 1993, Biochemical pharmacology.

[138]  G. Siest,et al.  Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. , 1989, Biochemical pharmacology.

[139]  E. Mayatepek,et al.  S-Acetylglutathione normalizes intracellular glutathione content in cultured fibroblasts from patients with glutathione synthetase deficiency , 2004, Journal of Inherited Metabolic Disease.

[140]  I. Phillips,et al.  Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. , 2001, Biochemical pharmacology.

[141]  H. Rosenkranz,et al.  Comparative effects of topically applied nitrated arenes and their nonnitrated parent arenes on cutaneous and hepatic drug and carcinogen metabolism in neonatal rats. , 1986, Toxicology and applied pharmacology.

[142]  T. Ngawhirunpat,et al.  Age difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. , 2001, Biological & pharmaceutical bulletin.

[143]  K. Wittern,et al.  NAD(P)H:Quinone Reductase Activity in Human Epidermal Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.

[144]  F. Oesch,et al.  Specificity of human, rat and mouse skin epoxide hydratase towards K-region epoxides of polycyclic hydrocarbons. , 1978, Biochemical pharmacology.

[145]  E. Jourdan,et al.  Zinc‐metallothionein genoprotective effect is independent of the glutathione depletion in HaCaT keratinocytes after solar light irradiation , 2004, Journal of cellular biochemistry.

[146]  J. Voorhees,et al.  The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. , 1997, The Journal of investigative dermatology.

[147]  H. Mukhtar,et al.  Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz(a)anthracene and beta-naphthoflavone. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[148]  S. Boyce,et al.  Methods for the Serum-Free Culture of Keratinocytes and Transplantation of Collagen-GAG-Based Skin Substitutes. , 1999, Methods in molecular medicine.

[149]  M. Taimi,et al.  CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids. , 2004, The Journal of biological chemistry.

[150]  R. Agarwal,et al.  Purification and molecular characterization of beta-naphthoflavone-inducible cytochrome P-450 from rat epidermis. , 1992, The Journal of investigative dermatology.

[151]  C. Chignell,et al.  Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. , 2004, Chemical research in toxicology.

[152]  Nesrin Emekli,et al.  Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. , 2005, Life sciences.

[153]  A. Roberts,et al.  Involvement of Smad Signaling in Sphingosine 1-Phosphate-mediated Biological Responses of Keratinocytes* , 2004, Journal of Biological Chemistry.

[154]  J. Bridges,et al.  Cytochrome P-450 dependent deethylase activity in rat and hairless mouse skin microsomes. , 1982, Biochemical pharmacology.

[155]  K. Sayama,et al.  A Novel Function of Angiotensin II in Skin Wound Healing , 2006, Journal of Biological Chemistry.

[156]  H. Törmä,et al.  Vitamin A esterification in human epidermis: a relation to keratinocyte differentiation. , 1990, The Journal of investigative dermatology.

[157]  M. Mulero,et al.  Parameters related to oxygen free radicals in erythrocytes, plasma and epidermis of the hairless rat. , 2002, Life sciences.

[158]  M. Rerek,et al.  Percutaneous Absorption of Sunscreens Through Micro-Yucatan Pig Skin In Vitro , 1999, Pharmaceutical Research.

[159]  P. Capel,et al.  Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase. , 1987, Gastroenterology.

[160]  A. Y. Lu,et al.  Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[161]  M. Briggs Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons , 1973, The British journal of dermatology.

[162]  G. Ailhaud,et al.  Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. , 2000, The Journal of investigative dermatology.

[163]  Kaori Matsumoto,et al.  Utility of a three-dimensional cultured human skin model as a tool to evaluate the simultaneous diffusion and metabolism of ethyl nicotinate in skin. , 2004, Drug metabolism and pharmacokinetics.

[164]  T Kurihara-Bergstrom,et al.  Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. , 1986, Laboratory animal science.

[165]  T. Boyer,et al.  Characterization of glutathione S-transferase in cultured human keratinocytes. , 1991, The Journal of investigative dermatology.

[166]  H. Mukhtar,et al.  Differences in inducibility of cytochrome P-4501A1, monooxygenases and glutathione S-transferase in cutaneous and extracutaneous tissues after topical and parenteral administration of beta-naphthoflavone to rats. , 1993, The International journal of biochemistry.

[167]  A. Honda,et al.  Effect of YM 9429, a potent teratogen, on cholesterol biosynthesis in cultured cells and rat liver microsomes , 1996, Steroids.

[168]  H. Jörnvall,et al.  Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. , 1999, Biochemical pharmacology.

[169]  H. Mukhtar,et al.  Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. , 2000, The Journal of investigative dermatology.

[170]  S. Shuster,et al.  Induction of drug metabolising enzymes in the skin by topical steroids. , 1984, Journal of steroid biochemistry.

[171]  Oliver Hankinson,et al.  CYP2S1: a short review. , 2005, Toxicology and applied pharmacology.

[172]  H. Mukhtar,et al.  Cytochrome p450: a target for drug development for skin diseases. , 2004, The Journal of investigative dermatology.

[173]  S. Roychowdhury,et al.  Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin , 2005, The AAPS Journal.

[174]  H. Glatt,et al.  The apparent ubiquity of epoxide hydratase in rat organs. , 1977, Biochemical pharmacology.

[175]  L. Wattenberg,et al.  HISTOCHEMICAL DEMONSTRATION OF REDUCED PYRIDINE NUCLEOTIDE DEPENDENT POLYCYCLIC HYDROCARBON METABOLIZING SYSTEMS , 1962 .

[176]  J. Mey,et al.  Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. , 2006, The Journal of investigative dermatology.

[177]  F. Dilworth,et al.  cDNA Cloning of Human Retinoic Acid-metabolizing Enzyme (hP450RAI) Identifies a Novel Family of Cytochromes P450 (CYP26)* , 1997, The Journal of Biological Chemistry.

[178]  S. Hotchkiss,et al.  Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. , 1997, Toxicology and applied pharmacology.

[179]  H. Glatt,et al.  Interindividual comparison of epoxide hydratase and glutathione S-transferase activities in cultured human fibroblasts. , 1980, Carcinogenesis.

[180]  M. Meurer,et al.  Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents – a preliminary study , 1999, Archives of Dermatological Research.

[181]  D. Migliore-Samour,et al.  Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation , 2001, The British journal of dermatology.

[182]  R. Eckert,et al.  The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. , 1997, Physiological reviews.

[183]  H. Mukhtar,et al.  Age-related changes in benzo(a)pyrene metabolism and epoxide-metabolizing enzyme activities in rat skin. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[184]  H. Mukhtar,et al.  Glutathione-S-epoxide transferase in mouse skin and human foreskin. , 1976, The Journal of investigative dermatology.

[185]  Franz Oesch,et al.  Chapter 4 – Xenobiotic Metabolism , 1999 .

[186]  P. G. Wells,et al.  UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. , 1997, The Journal of pharmacology and experimental therapeutics.

[187]  I. Bernstein,et al.  Levels of cytochrome P-450-mediated aryl hydrocarbon hydroxylase (AHH) are higher in differentiated than in germinative cutaneous keratinocytes. , 1990, The Journal of investigative dermatology.

[188]  K. Schittkowski,et al.  Modeling of diffusion and concurrent metabolism in cutaneous tissue. , 2000, Journal of theoretical biology.

[189]  S. Ekins,et al.  The role of CYP2B6 in human xenobiotic metabolism. , 1999, Drug metabolism reviews.

[190]  B. Lake,et al.  Expression and alternative splicing of the cytochrome P-450 CYP2A7. , 1995, The Biochemical journal.

[191]  P. G. Wells,et al.  Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. , 1995, Cancer research.

[192]  C. Fritsch,et al.  Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes , 1996, Archives of Dermatological Research.

[193]  H. Volk,et al.  Efficient in vitro transduction of epithelial cells and keratinocytes with improved adenoviral gene transfer for the application in skin tissue engineering. , 2002, Transplant immunology.

[194]  W. Dressler,et al.  Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[195]  T. Phillips,et al.  Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content. , 1986, International journal of radiation oncology, biology, physics.

[196]  G. Nohynek,et al.  Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. , 2005, Toxicology letters.

[197]  M. Fujii,et al.  The effect of ethanol on the simultaneous transport and metabolism of methyl p-hydroxybenzoate in excised skin of Yucatan micropig. , 2002, International journal of pharmaceutics.

[198]  I. Merkatz,et al.  Induction of Benzo[α]pyrene Hydroxylase in Human Skin , 1972, Science.

[199]  A. Billich,et al.  Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. , 2001, International journal of pharmaceutics.

[200]  A. Mavon,et al.  Skin absorption and metabolism of a new vitamin E prodrug, delta-tocopherol-glucoside: in vitro evaluation in human skin models. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[201]  C. Gomez-Sanchez,et al.  Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[202]  J. Stegeman,et al.  On the species-specific biotransformation of dibenzo[a,l]pyrene. , 2006, Chemico-biological interactions.

[203]  A. Malmström,et al.  Glucocorticoids change the nucleotide and sugar nucleotide pool sizes in cultured human skin fibroblasts. , 1987, Archives of biochemistry and biophysics.

[204]  R. Tukey,et al.  Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties. , 1994, Archives of biochemistry and biophysics.

[205]  N. A. Santagati,et al.  Ketoprofen 1-Alkylazacycloalkan-2-one Esters as Dermal Prodrugs: In Vivo and In Vitro Evaluations , 2003, Drug development and industrial pharmacy.

[206]  H. Mukhtar,et al.  Cytochrome P-450 dependent metabolism of testosterone in rat skin. , 1987, Biochemical and biophysical research communications.

[207]  B. Christ,et al.  Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. , 2003, ALTEX.

[208]  A. Slominski,et al.  Serotonin metabolism in rat skin: characterization by liquid chromatography-mass spectrometry. , 2004, Archives of biochemistry and biophysics.

[209]  Amy Li,et al.  Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. , 2004, The Journal of clinical investigation.